Navigation Links
The Real Skinny on a Vivid Way to Scope Out Questionable Moles or Skin Bumps
Date:11/19/2013

BOSTON, Nov. 19, 2013 /PRNewswire/ -- Humans need the sun. People might complain about sunburn, age spots or leathery skin, but they need the sun's rays. The warmth and glow of the sun significantly improves mood and makes for great vacation weather, but most importantly it supplies vitamin D—necessary for bone growth, calcium production and immune system strength. As with all good things in life, however, sun exposure needs to be moderated. Slathering on sunscreen, even with an SPF of 50 or more, is not enough. It's no secret that extended sun exposure, while enjoyable, can lead to skin cancer.

According to the American Academy of Dermatology, one in five Americans will develop skin cancer over the course of their lifetime. Although sun exposure and other environmental factors can cause skin cancer, a family history of fair and freckled skin can also be a risk factor.

So what can be done? People are not going to cover up every bit of skin and stay inside all day. Rather, they need to practice responsible behaviors with regard to the sun. Most importantly, though, they need to self-monitor their skin by keeping track of moles, watching to see if they change color, size or shape.

The next and perhaps most important step is to report any visible changes to one's doctor. It's never a good idea to play the waiting game.

One reason people are hesitant to go to a doctor is because biopsies are often painful and invasive, and can leave unwanted scarring.

Enter VivaScope®, a cellular imaging device designed by Caliber Imaging & Diagnostics.

VivaScope can take pictures of an entire lesion layer by layer, and can immediately rule out or diagnose most skin diseases and disorders. Since there is no cutting involved, there is also no possibility of infection or scarring. Obtaining an image takes just a few minutes so the doctor can make a determination at the bedside, or the image can be transferred within minutes through the company's VivaNet® system, so that a pathologist can diagnose it remotely.

For more information on VivaScope, visit www.caliberid.com, who paid for the writing and dissemination of this release.

Contact: Laura Radocaj, Dian Griesel Int'l., 212.825.3210


'/>"/>
SOURCE Caliber Imaging & Diagnostics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
2. Middle East and Africa Endoscopy Devices Market Outlook to 2017 - Flexible Endoscopes, Rigid Endoscopes, Endoscopy Visualization Systems, Capsule Endoscope Systems and Others
3. Telescope Implant for End Stage Macular Degeneration Now Available Across the Nation
4. Healthscope to commercially launch Circadians Cancers of Unknown Primary Diagnostic Test
5. Middle East and Africa Endoscopy Devices Market Outlook to 2017 - Flexible Endoscopes, Rigid Endoscopes, Endoscopy Visualization Systems, Capsule Endoscope Systems and Others
6. Verathon, maker of GlideScope video laryngoscopes, provides free educational DVD to promote best practices in pediatric airway management.
7. Texas Childrens Hospital is first in North America to own Leica Microsystems Gated Stimulation Emission Depletion microscope
8. Caliber IDs VivaScope technology found to be 100% sensitive for basal cell carcinoma diagnosis
9. Richard Wolf Introduces the Smallest Bipolar Resectoscope on the Market
10. VisionCare Implantable Telescope Technology Presentations Featured at Upcoming American Academy of Ophthalmology and Ophthalmology Innovation Summit Meetings
11. VisionCare Receives Health Canada License for First-Ever Telescope Prosthesis for End-Stage Macular Degeneration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 2017  Novartis announced today that the US ... company,s Biologics License Application (BLA) filing and granted ... antigen receptor T cell (CAR-T) therapy, in relapsed ... with B-cell acute lymphoblastic leukemia (ALL). This is ... CAR-T. The priority review designation is expected to ...
(Date:3/29/2017)... , March 29, 2017  The Global Health ... public-private partnership formed to battle infectious diseases around ... US$23 million* that could help deliver a range ... debilitating conditions. This latest round ... 3 clinical trial testing a pediatric formulation of ...
(Date:3/29/2017)... FREMONT, Calif. , March 29, 2017 /PRNewswire/ ... vision for patients as the highest standard in ... Today, Krypton Vision introduces its objective Wavefront-driven refraction ... conventional, subjective approach. This enables an unprecedented level ... optics - exceptional vision relegated to Topgun Navy ...
Breaking Medicine Technology:
(Date:3/30/2017)... ... March 30, 2017 , ... Watch the video ... Month, representatives from Organic Consumers Association, National Health Freedom Action, March Against Monsanto, ... Voice for Choice, Moms Across America, Freedom and Ethics Alliance and the Vaccine ...
(Date:3/30/2017)... (PRWEB) , ... March 30, 2017 , ... ... host the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ” ... 2017 at 1:00 pm ET. This conference discusses strategies to prevent readmissions in ...
(Date:3/29/2017)... WI (PRWEB) , ... March 29, 2017 , ... ARI ... its exclusive provider of co-op eligible dealer websites for its network of more than ... of professional landscaping and agricultural equipment including rotary and flail mowers and cutters, rear ...
(Date:3/29/2017)... ... March 29, 2017 , ... Full Contact K9, an ... Pet Protect Law that assists dog owners in creating legally-enforceable pet trusts ... in taking the natural next step to protect their new companion. Says Evan Dunbar, ...
(Date:3/29/2017)... ... ... Youth Futures International (YFI) premiered its Serve, Learn, & Empower program in ... who have participated in the program every summer. The 2017 Serve, Learn, & ... enrollment. Visit http://www.ghana.yfiexperience.org to learn more. , “I have sent my ...
Breaking Medicine News(10 mins):